Avinger to Present at Oppenheimer Healthcare Conference on March 20
REDWOOD CITY, CA / ACCESSWIRE / March 1, 2019 / Avinger, Inc. (NASDAQ: AVGR), a…
Uncategorized
New Paper Relevant for the Optimal Development of Drugs Targeting LSD1 Published by ORYZON
Uses proprietary chemoprobe technology to demonstrate target engagement, key to drug development and rational dosing…
ITOCO – Camedco JV Creates Future Leader in Medical Cannabis
TORONTO, ON / ACCESSWIRE / February 27, 2019 / Itoco Inc (OTC PINK: ITMC), has…
Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium
– Preliminary data suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment…
Evotec Receives Milestone Payment For Start Of Second Phase II Trial In Its Multi-Target Alliance With Bayer
PHASE II CLINICAL TRIAL ON PERSISTENT CHRONIC COUGH HAMBURG, GERMANY / ACCESSWIRE / February 28,…
Theralase Named to 2019 TSX Venture 50(TM)
Theralase Achieves Third Place in the Clean Technology and Life Sciences Category on the 2019…
EviTrade Provides Update on Hemp Based Extraction and Processing Facility
VANCOUVER, BC / ACCESSWIRE / February 28, 2019 / EVITRADE Health Systems Corp. (CSE: EVA,…
Meet IKU DAO: The Company Prioritizing Drug Discovery By The Consumers
DALLAS, TX / ACCESSWIRE / February 26, 2019 / What if there was a way…
MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / February 27, 2019 / MorphoSys AG (FSE: MOR)…
Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR
Data identifies a simple blood test that predicts clinical response to pelareorep CALGARY, AB and…